Pall Corp. has acquired GeneSystems, a privately held biotechnology company that has developed its own molecular diagnostics platform. The acquisition expands Pall’s Total Fluid Management (TFM) capabilities in the biopharmaceuticals process monitoring market with GeneSystems’ rapid microbiological detection equipment and disposables.       Process monitoring includes the analytical tests required during biopharmaceuticals manufacturing for environmental monitoring, in-process con...